ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR was delisted on the 27th of May, 2025.
12 hedge funds and large institutions have $4.96M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
71% more capital invested
Capital invested by funds: $2.89M → $4.96M (+$2.06M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
23.29% more ownership
Funds ownership: 0% → 23.29% (+23%)
20% more funds holding
Funds holding: 10 → 12 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$3.12M |
| 2 |
Jane Street
New York
|
+$716K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$279K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.25M |
| 2 |
LPL Financial
San Diego,
California
|
-$250K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$23K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
BCWM LLC
Overland Park,
Kansas
| $2.89M | +$3.12M | +135,966 | New |
|
|
2
Jane Street
New York
| $888K | +$716K | +31,150 | +292% |
|
|
3
LPL Financial
San Diego,
California
| $551K | -$250K | -10,879 | -30% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $305K | +$15.2K | +661 | +5% |
|
|
5
Citadel Advisors
Miami,
Florida
| $257K | +$279K | +12,144 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $24K | +$26.2K | +1,141 | New |
|
|
BBPWM
7
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $17K | – | – | – |
|
|
GT
8
Glenmede Trust
Philadelphia,
Pennsylvania
| $14K | – | – | – |
|
|
MFS
9
MSI Financial Services
Springfield,
Massachusetts
| $6K | +$2.64K | +115 | +61% |
|
|
AG
10
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | -$23K | -1,000 | -94% |
|
|
SFS
12
Sowell Financial Services
North Little Rock,
Arkansas
| $1K | +$1.15K | +50 | New |
|
|
13
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.25M | -48,628 | Closed |
|
|
14
Creative Planning
Overland Park,
Kansas
| – | -$3K | -100 | Closed |
|
CNCR Hedge Fund Activity: Q4 2016 in Review
12 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) for Q4 2016, worth a combined $4.96M — up 71% from $2.89M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CNCR positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was BCWM LLC, opening a new position worth an estimated $3.12M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.25M sold.
- 12 institutional investors held ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) as of Q4 2016, up from 10 in Q3 2016.
- Funds reported $4.96M of ETF Series Solutions Trust Range Cancer Therapeutics ETF stock for Q4 2016, up 71% quarter-over-quarter.
- 4 funds opened new ETF Series Solutions Trust Range Cancer Therapeutics ETF positions in Q4 2016 and 2 closed out, a net change of +2 holders.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF buyer in Q4 2016 was BCWM LLC, an estimated $3.12M added.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF seller in Q4 2016 was Susquehanna International Group, an estimated $1.25M sold.
Based on aggregated 13F filings for Q4 2016.